Suit Alleges Conspiracy Among Drug Cos., Wholesalers

Law360, New York (July 20, 2006, 12:00 AM EDT) -- A Long Island-based drug wholesaler is targeting 16 pharmaceutical companies in a federal antitrust suit that seeks damages in excess of $2.3 billion and makes sweeping claims about anticompetitive conduct in the pharmaceutical industry.

RxUSA Wholesale Inc.’s 167-page complaint, filed in the U.S. District Court for the Eastern District of New York, contains 23 counts, and alleges that the defendants—which include Sanofi-Aventis, Schering-Plough, Wyeth, Merck and Pfizer, as well as five drug wholesalers—are colluding to smother competition.

The complaint also claims that certain defendants violated federal...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.